1
TITLE: Corrigendum to “The adipose tissue melanocortin 3 receptor is targeted by ghrelin and leptin and may be a therapeutic target in obesity” [Mol. Cell. Endocrinol. 594 (2024), 112367]  Full Text
AUTHORS: Daniela Rosendo-Silva; Eduardo Lopes; Tamaeh Monteiro-Alfredo; Inês Falcão-Pires; Hans Eickhoff; Sofia Viana; Flávio Reis; Ana Salomé Pires; Ana Margarida Abrantes; Maria Filomena Botelho; Raquel Seiça; Paulo Matafome;
PUBLISHED: 2025, SOURCE: Molecular and Cellular Endocrinology, VOLUME: 595
INDEXED IN: CrossRef
IN MY: ORCID
2
TITLE: Front Cover: Targeting of G‐quadruplex DNA with 99mTc(I)/Re(I) Tricarbonyl Complexes Carrying Pyridostatin Derivatives (Chem. Eur. J. 22/2024)
AUTHORS: Elisa Palma; Cigdem Içhedef; Célia Fernandes; Ana Belchior; Paula Raposinho; Lurdes Gano; André Miranda; David Moreira; Pedro Lourenço; Carla Cruz; Ana Salomé Pires; Maria Filomena Botelho; António Paulo;
PUBLISHED: 2024, SOURCE: Chemistry – A European Journal, VOLUME: 30, ISSUE: 22
INDEXED IN: CrossRef
IN MY: ORCID
3
TITLE: Radiobiology of Accidental, Public, and Occupational Exposures
AUTHORS: Ruth Wilkins; Ana Margarida Abrantes; Elizabeth Ainsbury; Sarah Baatout; Maria Filomena Botelho; Tom Boterberg; Alžbĕta Filipová; Daniela Hladik; Felicia Kruse; Inês Alexandra Marques; Dhruti Mistry; Jayne Moquet; Ursula Oestreicher; Raghda Ramadan; Georgia Terzoudi; Sotiria Triantopoulou; Guillaume Vogin; Anne-Sophie Wozny;
PUBLISHED: 2023, SOURCE: Radiobiology Textbook
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID
4
TITLE: Individual Radiation Sensitivity and Biomarkers: Molecular Radiation Biology
AUTHORS: Elizabeth A Ainsbury; Ana Margarida Abrantes; Sarah Baatout; Ans Baeyens; Maria Filomena Botelho; Benjamin Frey; Nicolas Foray; Alexandros G Georgakilas; Fiona M Lyng; Inês Alexandra Marques; Aidan D Meade; Mirta Milic; Dhruti Mistry; Jade F Monaghan; Alegría Montoro; Ana Salomé Pires; Georgia I Terzoudi; Sotiria Triantopoulou; Kristina Viktorsson; Guillaume Vogin;
PUBLISHED: 2023, SOURCE: Radiobiology Textbook
INDEXED IN: CrossRef: 2
IN MY: ORCID